ark

Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD

SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration…

1 week ago

Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys for the Treatment of ADHD

SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration…

2 weeks ago

NOAH Holdings | ARK Wealth H2 CIO Report: Technology-Driven Deflation and Efficiency Dividends Are Reshaping Asset Allocation

The Report explores a dual-track economic structure, balancing structural inflation with deep deflation driven by technological disruption.Technology-driven deflation is projected…

5 months ago

Noah Holdings and ARK Wealth Hosts Inaugural Global Chinese Wealth Management and Inheritance Summit in Singapore

—— Shaping Resilient and Innovative Allocation Strategies for the Future SINGAPORE, Aug. 1, 2025 /PRNewswire/ -- Noah Holdings Limited's ("Noah" or…

6 months ago